San Diego-based Viking Therapeutics marked itself as a serious competitor within the weight loss drug current market in February soon after revealing promising facts from the mid-phase trial of experimental drug VK2735, which prompt it rivaled—and outperformed—Novo and Lilly drugs when given like a weekly injection and in March the company unve